thymic carcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Any (1)

Phase 1 (1)

Interventional (1)

Vastra Gotaland Region (1)

No (1)

No (1)

Adult (18+) (1)

dept (1)
oncolog (1)

I am/have/had

I am/have/hadbilateral salpingectomy

I am/have/hadneutrophil count

I am/have/hadprogressive disease

I am/have/hadsomatostatin

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadluteinizing hormone

I am/have/hadserum pregnancy test

I am/have/hadplatelet count

I am/have/hadneuroendocrine tumor

I am/have/hadcomplete resection

I am/have/hadliver metastasis

I am/have/hadhysterectomy

I am/have/hadthymoma

I am/have/hadoophorectomy

I am/have/hadbilateral oophorectomy

I am/have/hadki-67

I am/have/hadhormone levels

I am/have/hadneuroendocrine tumors

I am/have/hadmeningioma

added new label for I am/have/had

more

I am looking for

I am looking forfollicle stimulating hormone

I am looking fordotatate

I am looking forolaparib

I am looking forsomatostatin

I am looking fortetraxetan

I am looking forluteinizing hormone

I am looking forparp inhibitor

I am looking forfollicle-stimulating hormone

I am looking fordota-tate

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

This is a phase I study of 177Lu-DOTA-TATE in combination with the PARP-inhibitor olaparib for treatment of patients with somatostatin receptor positive tumours detected by 68Ga-DOTA-TATE/TOC PET. The combination of a PARP inhibitor that will specifically target the repair mechanism, with ionising radiation causing SSB's might overcome the repair dependent …

follicle stimulating hormone

bilateral salpingectomy

progressive disease

neutrophil count

olaparib

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.